Nuvectis Pharma Inc.

6.46
-0.23 (-3.44%)
At close: Mar 03, 2025, 11:51 AM

Nuvectis Pharma Ratios Statement

Year FY24 FY23 FY22 FY21 FY20
PE Ratio -4.87 -5.83 -5.05 -3.21 -4.13K
PEG Ratio 0.22 1.73 -0.11 -0.00 n/a
PS Ratio n/a n/a 637.13 n/a n/a
PB Ratio 9.53 10.63 6.68 -3.75 -4.13K
P/FCF Ratio -7.56 -8.13 -7 -4.35 1.72K
P/OCF Ratio -7.56 -8.13 -7 -4.35 1.72K
OCF/S Ratio n/a n/a -91 n/a n/a
Debt / Equity Ratio n/a n/a n/a n/a n/a
Quick Ratio 2.09 2.75 3.30 2.41 n/a
Current Ratio 2.09 2.75 3.30 2.41 n/a
Asset Turnover n/a n/a 0.01 n/a n/a
Interest Coverage n/a n/a -129.09 n/a n/a
Return on Equity (ROE) -1.96 -1.82 -1.32 1.17 1.00
Return on Assets (ROA) -1.02 -1.16 -0.92 -1.94 n/a
Return on Capital (ROIC) n/a -1.88 -1.35 -3.04 1.00
Dividend Yield n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a -12.81K% n/a n/a
Net Profit Margin n/a n/a -12.61K% n/a n/a
Pretax Profit Margin n/a n/a -12.81K% n/a n/a
Operating Profit Margin n/a n/a -12.91K% n/a n/a
FCF Margin n/a n/a -9.1K% n/a n/a
EBITDA Margin n/a n/a -12.91K% n/a n/a